Our data suggested that IGF2BP3, NSUN7, EXO1, and FBXO17 were highly expressed in AC-, MES-, NPC-, and OPC-like malignant cells, which could be related to poor prognosis for glioma patients. The gene discussed is FBXO17; the disease is central nervous system cancer.